NCT03129867View on ClinicalTrials.gov

ADHerence of ticagrelOr in Real World Patients With aCute Coronary Syndrome

CompletedOBSERVATIONAL
Enrollment

480

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

March 31, 2020

Study Completion Date

December 31, 2020

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Ticagrelor

Ticagrelor 60mg or 90 mg as routine use of each Center

All Listed Sponsors
lead

FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS

OTHER

NCT03129867 - ADHerence of ticagrelOr in Real World Patients With aCute Coronary Syndrome | Biotech Hunter | Biotech Hunter